SLCO1B3 and chronic myelogenous leukemia, BCR-ABL1 positive: Since CML cells mainly use OCT1 and OATP1B3 for the uptake of imatinib,14 it is important to determine whether a dye uptake behavior similar to that of hepatocytes can be observed in CML cells.